Biological specificity of CDK4/6 inhibitors: dose response relationship,in vivosignaling, and composite response signature

Abstract excerpt

// Erik S. Knudsen 1,2 , Jack Hutcheson 4 , Paris Vail 1,2 and Agnieszka K. Witkiewicz 1,3 1 University of Arizona Cancer Center, Tucson, AZ, USA 2 Department of Medicine, University of Arizona, Tucson, AZ, USA 3 Department of Pathology, University of Arizona, Tucson, AZ, USA 4 Tri-Service Research Laboratory, San Antonio, TX, USA Correspondence to: Erik S. Knudsen, email: // Agnieszka K. Witkiewicz, email: //...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced Breast Cancer Therapies
• Share to Cancer-related Molecular Pathways
• Share to Chronic Lymphocytic Leukemia Research